@babykailan74@jfais20 reports have ranged from 24 - 40% as elevated enzymes, not severe liver injury. Think that is an apples and oranges comparison. So far however, $rgnx looks promising.
@MrClister I have no idea but I like to speculate. Buyout never, too much debt and each drugs' future is uncertain. Change of leadership? Yes. This could be Doug leaving or even some other senior mgmt change.
@MarkSharkKing@AudonThiggy@Forever_DNA I can't agree more. Trust/believability of this management is forever gone. Beside debt issues, $srpt has 4 approved drugs over 8 years and nothing to show for it other than excessive spending and increased share float. Potential is still there.
@TrumpsHurricane Really? She is a sweety, she just needs to lose the glasses and let the hair down and I bet she would be very attractive to MAGA men and all others.
@yachmod@Sarepta@douglas_ingram Why is it that we almost insist it will turn itself around again? I know i'm guilty of that, but I use to have reasons.